Investor Briefcase

Notice of meeting

Issue link: https://resources.liminalbiosciences.com/i/1077774

Contents of this Issue

Navigation

Page 0 of 2

NOTICE OF 2019 ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS AND NOTICE OF AVAILABILITY OF MEETING MATERIALS 1 Notice of meeting NOTICE IS HEREBY GIVEN THAT the Annual and Special Meeting of Shareholders (the "Meeting") of Prometic Life Sciences Inc. (the "Corporation" or "Prometic") will be held on Wednesday, June 19, 2019 at 10:30 a.m. (Montreal time) at the Centre Mont-Royal, Room Cartier 1 & 2, 2200, rue Mansfield, Montreal, Quebec, Canada for the following purposes: 1 to receive the consolidated financial statements of the Corporation for the financial year ended December 31, 2018 and the auditors' report thereon (for details, see subsection "Financial Statements and Auditor's Report" under the "Business of the Meeting" section of the management information circular of the Corporation dated May 7, 2019 (the "Management Information Circular")); 2 to elect the directors for the ensuing year (for details, see subsection "Election of Directors" under the "Business of the Meeting" section of the Management Information Circular); 3 to appoint the auditors for the ensuing year and to authorize the directors to fix their remuneration (for details, see subsection "Appointment of Auditors" under the "Business of the Meeting" section of the Management Information Circular); 4 to consider and, if deemed advisable, pass an ordinary resolution of the shareholders, the full text of which is reproduced in Schedule "D" to the Management Information Circular, to approve the Omnibus Incentive Plan of the Corporation (the "Omnibus Incentive Plan") (for details, see subsection "Omnibus Incentive Plan" under the "Business of the Meeting" section of the Management Information Circular); 5 to consider and, if deemed advisable, pass a special resolution (the "Consolidation Resolution"), the full text of which is reproduced in Schedule "E" to the Management Information Circular, authorizing the Board of Directors of the Corporation (the "Board") to amend the articles of the Corporation to effect a consolidation of all of the issued and outstanding common shares of the Corporation (the "Common Shares"), on the basis of a consolidation ratio to be selected by the Board within a range between seven hundred fifty (750) pre- consolidation Common Shares for one (1) post-consolidation Common Share and one thousand two hundred fifty (1250) pre-consolidation Common Shares for one (1) post-consolidation Common Share (the "Share Consolidation"), effective as at the discretion of the Board (for details, see subsection "Share Consolidation" under the "Business of the Meeting" section of the Management Information Circular); and 6 to transact such other business as may properly be brought before the Meeting or any reconvened meeting following its adjournment or postponement. Shareholders are reminded to review the Management Information Circular carefully before voting because it has been prepared to help you make an informed decision. 1.1 Notice-and-Access This year, as permitted by Canadian securities regulators, you are receiving this notification as the Corporation has decided to use the "notice-and-access" mechanism for delivery to the shareholders of this notice of annual and special meeting of shareholders, the Management Information Circular and other proxy-related materials (the "Meeting Materials") as well as the annual audited consolidated financial statements of the Corporation for the financial year ending December 31, 2018, together with the independent auditor's report thereon and related management's discussion and analysis (together, the "Financial Statements"). Notice-and-access is a set of rules that allows issuers Prometic Life Sciences Inc. 2019 Management Information Circular

Articles in this issue

view archives of Investor Briefcase - Notice of meeting